MindMaze Therapeutics Appoints Prof. John W. Krakauer as Strategic Advisor

AI SummaryClose X

MindMaze Therapeutics Holding SA has appointed Professor John W. Krakauer as a strategic advisor to support its expansion in the United States, leveraging his expertise in motor neuroscience and neurorehabilitation, particularly his foundational work on the high-dose, high-intensity paradigm that underpins the company's MindPod system. This appointment follows a period of significant progress for MindMaze, including a real-world evidence program demonstrating a 60% increase in delivered therapy per day and 17% higher community discharge rates, the establishment of a U.S. headquarters, and a go-to-market partnership with Vibra Healthcare.

Disclaimer*

UK 100

Latest directors dealings